Search Results - "Jenkins, B. R."

Refine Results
  1. 1
  2. 2

    Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831 by Roche, Patrick C., Suman, Vera J., Jenkins, Robert B., Davidson, Nancy E., Martino, Silvana, Kaufman, Peter A., Addo, Ferdinand K., Murphy, Bronagh, Ingle, James N., Perez, Edith A.

    “…The efficacy of trastuzumab for metastases coupled with the relatively poor prognosis of patients with node-positive, HER2-positive breast cancer has led to…”
    Get full text
    Journal Article
  3. 3

    Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the Message by TUBBS, R. R, PETTAY, J. D, ROCHE, P. C, STOLER, M. H, JENKINS, R. B, GROGAN, T. M

    Published in Journal of clinical oncology (15-05-2001)
    “…Several studies have reported what seem to be false-positive results using the Food and Drug Administration (FDA)-approved HercepTest (Dako Corp, Carpinteria,…”
    Get full text
    Journal Article
  4. 4

    Patterns and ecological predictors of age-related performance in female North American barn swallows, Hirundo rustica erythrogaster by Bradley, R. J, Hubbard, J. K, Jenkins, B. R, Safran, R. J

    Published in Behavioral ecology and sociobiology (01-11-2014)
    “…Life history theory describes the optimization of important trade-offs within an individual’s lifetime and predicts that an individual’s reproductive…”
    Get full text
    Journal Article
  5. 5

    A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy by Ross, A E, Feng, F Y, Ghadessi, M, Erho, N, Crisan, A, Buerki, C, Sundi, D, Mitra, A P, Vergara, I A, Thompson, D J S, Triche, T J, Davicioni, E, Bergstralh, E J, Jenkins, R B, Karnes, R J, Schaeffer, E M

    Published in Prostate cancer and prostatic diseases (01-03-2014)
    “…Background: Due to their varied outcomes, men with biochemical recurrence (BCR) following radical prostatectomy (RP) present a management dilemma. Here, we…”
    Get full text
    Journal Article
  6. 6

    Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis by Jaeckle, K. A., Decker, P. A., Ballman, K. V., Flynn, P. J., Giannini, C., Scheithauer, B. W., Jenkins, R. B., Buckner, J. C.

    Published in Journal of neuro-oncology (01-08-2011)
    “…Glioblastomas (GBM) may originate de novo (primary), or following transformation from a lower grade glioma (secondary), and it has been postulated that these…”
    Get full text
    Journal Article
  7. 7

    Clinical Significance of Alterations of Chromosome 8 in High-Grade, Advanced,Nonmetastatic Prostate Carcinoma by Sato, Kazunari, Qian, Junqi, Slezak, Jeffrey M., Lieber, Michael M., Bostwick, David G., Bergstralh, Erik J., Jenkins, Robert B.

    “…BACKGROUND: Chromosome 8 alterations, including loss of 8p21-22 and gain of 8q24, are commonly observed in prostate carcinoma. We examined whether these…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas by SMITH, J. S, PERRY, A, JENKINS, R. B, BORELL, T. J, LEE, H. K, O'FALLON, J, HOSEK, S. M, KIMMEL, D, YATES, A, BURGER, P. C, SCHEITHAUER, B. W

    Published in Journal of clinical oncology (01-02-2000)
    “…A recent report suggests that alterations of chromosome arms 1p and 19q are associated with chemotherapeutic response and overall survival in anaplastic…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Sporadic medulloblastomas contain PTCH mutations by RAFFEL, C, JENKINS, R. B, FREDERICK, L, HEBRINK, D, ALDERETE, B, FULTS, D. W, JAMES, C. D

    Published in Cancer research (Chicago, Ill.) (01-03-1997)
    “…Nevoid basal cell carcinoma syndrome (NBCCS), or Gorlin's syndrome, is an autosomal dominant disorder that predisposes to developmental defects and various…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype by SMITH, J. S, ALDERETE, B, FEUERSTEIN, B. G, BURGER, P. C, SCHEITHAUER, B. W, JENKINS, R. B, MINN, Y, BORELL, T. J, PERRY, A, MOHAPATRA, G, HOSEK, S. M, KIMMEL, D, O'FALLON, J, YATES, A

    Published in Oncogene (15-07-1999)
    “…Allelic alterations of chromosomes 1 and 19 are frequent events in human diffuse gliomas and have recently proven to be strong predictors of chemotherapeutic…”
    Get full text
    Journal Article
  14. 14

    Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization by JENKINS, R. B, QIAN, J, LIEBER, M. M, BOSTWICK, D. G

    Published in Cancer research (Chicago, Ill.) (01-02-1997)
    “…The role of c-myc in prostatic carcinogenesis is poorly understood. The pathogenetic relationship between high-grade prostatic intraepithelial neoplasia (PIN),…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI by Johnson, D R, Diehn, F E, Giannini, C, Jenkins, R B, Jenkins, S M, Parney, I F, Kaufmann, T J

    Published in American journal of neuroradiology : AJNR (01-04-2017)
    “…In 2016, the World Health Organization revised the brain tumor classification, making mutation and 1p/19q codeletion the defining features of…”
    Get full text
    Journal Article
  17. 17

    Human epithelial ovarian cancer allelotype by CLIBY, W, RITLAND, S, HARTMANN, L, DODSON, M, HALLING, K. C, KEENEY, G, PODRATZ, K. C, JENKINS, R. B

    Published in Cancer research (Chicago, Ill.) (15-05-1993)
    “…To determine which chromosomes and chromosomal regions contain putative tumor suppressor genes important for human epithelial ovarian cancer, we performed loss…”
    Get full text
    Journal Article
  18. 18

    Clinical outcome of gliosarcoma compared with glioblastoma multiforme : North Central Cancer Treatment Group results by GALANIS, E, BUCKNER, J. C, DINAPOLI, R. P, SCHEITHAUER, B. W, JENKINS, R. B, CHIAO HUA WANG, O'FALLON, J. R, FARR, G. JR

    Published in Journal of neurosurgery (01-09-1998)
    “…Gliosarcoma, a rare malignancy of the central nervous system, consists of gliomatous and sarcomatous elements. There are conflicting reports regarding its…”
    Get full text
    Journal Article
  19. 19
  20. 20

    PTEN/MMAC1 mutations and EGFR amplification in glioblastomas by LIU, W, JAMES, C. D, FREDERICK, L, ALDERETE, B. E, JENKINS, R. B

    Published in Cancer research (Chicago, Ill.) (01-12-1997)
    “…Loss of heterozygosity (LOH) from chromosome 10 is a hallmark of glioblastoma, the most malignant (grade IV) form of glioma. A candidate tumor suppressor gene,…”
    Get full text
    Journal Article